Literature DB >> 23127848

Chronic dopamine depletion augments the functional expression of K-ATP channels in the rat subthalamic nucleus.

Ke-Zhong Shen1, Steven W Johnson.   

Abstract

Symptoms of Parkinson's disease caused by dopamine depletion are associated with burst firing in the subthalamic nucleus (STN). Moreover, regularization or suppression of STN neuronal activity is thought to improve symptoms of Parkinson's disease. We reported recently that N-methyl-D-aspartate (NMDA) receptor stimulation of rat STN neurons evokes ATP-sensitive K(+) (K-ATP) current via a Ca(2+)- and nitric oxide-dependent mechanism. The present studies were done to determine whether or not K-ATP channel function in STN neurons is altered in a model of chronic dopamine depletion. Brain slices were prepared from rats with unilateral dopamine depletion caused by intracerebral 6-hydroxydopamine (6-OHDA) injections. Whole-cell patch-clamp recordings showed that NMDA evoked more outward current at -70 mV and greater positive slope conductance in STN neurons located ipsilateral to 6-OHDA treatment compared to neurons located contralateral. Moreover, extracellular, loose-patch recordings showed that NMDA increased spontaneous firing rate in STN neurons in slices from normal rats, whereas NMDA produced a tolbutamide-sensitive inhibition of firing rate in STN neurons located ipsilateral to 6-OHDA treatment. These results show that K-ATP channel function in STN neurons is up-regulated by chronic dopamine deficiency. We suggest that K-ATP channel activation in the STN might benefit symptoms of Parkinson's disease. Published by Elsevier Ireland Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23127848      PMCID: PMC3513517          DOI: 10.1016/j.neulet.2012.10.030

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  24 in total

Review 1.  Pathological basal ganglia activity in movement disorders.

Authors:  T Wichmann; J O Dostrovsky
Journal:  Neuroscience       Date:  2011-06-22       Impact factor: 3.590

2.  Dopamine depletion alters responses to glutamate and GABA in the rat subthalamic nucleus.

Authors:  Ke-Zhong Shen; Steven W Johnson
Journal:  Neuroreport       Date:  2005-02-08       Impact factor: 1.837

3.  Studies of ATP-sensitive potassium channels on 6-hydroxydopamine and haloperidol rat models of Parkinson's disease: implications for treating Parkinson's disease?

Authors:  Sen Wang; Li-Fang Hu; Yong Yang; Jian-Hua Ding; Gang Hu
Journal:  Neuropharmacology       Date:  2005-06       Impact factor: 5.250

4.  Alternative sulfonylurea receptor expression defines metabolic sensitivity of K-ATP channels in dopaminergic midbrain neurons.

Authors:  B Liss; R Bruns; J Roeper
Journal:  EMBO J       Date:  1999-02-15       Impact factor: 11.598

5.  Sulfonylurea binding sites in normal human brain and in Parkinson's disease, progressive supranuclear palsy and Huntington's disease.

Authors:  S Holemans; F Javoy-Agid; Y Agid; F De Paermentier; E C Laterre; J M Maloteaux
Journal:  Brain Res       Date:  1994-04-11       Impact factor: 3.252

6.  Excitation by dopamine of rat subthalamic nucleus neurones in vitro-a direct action with unconventional pharmacology.

Authors:  A Tofighy; A Abbott; D Centonze; A J Cooper; E Noor; S M Pearce; M Puntis; I M Stanford; M A Wigmore; M G Lacey
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

7.  Excitatory effects of dopamine on subthalamic nucleus neurons: in vitro study of rats pretreated with 6-hydroxydopamine and levodopa.

Authors:  Zitao Zhu; Muriel Bartol; Kezhong Shen; Steven W Johnson
Journal:  Brain Res       Date:  2002-07-26       Impact factor: 3.252

8.  The primate subthalamic nucleus. III. Changes in motor behavior and neuronal activity in the internal pallidum induced by subthalamic inactivation in the MPTP model of parkinsonism.

Authors:  T Wichmann; H Bergman; M R DeLong
Journal:  J Neurophysiol       Date:  1994-08       Impact factor: 2.714

9.  Potassium channels: possible new therapeutic targets in Parkinson's disease.

Authors:  Yan Wang; Peng-lin Yang; Ji-fei Tang; Jia-feng Lin; Xiao-hong Cai; Xiao-tong Wang; Guo-qing Zheng
Journal:  Med Hypotheses       Date:  2008-07-22       Impact factor: 1.538

10.  Modulation of GABA transmission by diazoxide and cromakalim in the globus pallidus: implications for the treatment of Parkinson's disease.

Authors:  Y P Maneuf; S Duty; C J Hille; A R Crossman; J M Brotchie
Journal:  Exp Neurol       Date:  1996-05       Impact factor: 5.330

View more
  5 in total

1.  Group I mGluRs evoke K-ATP current by intracellular Ca2+ mobilization in rat subthalamus neurons.

Authors:  Ke-Zhong Shen; Steven W Johnson
Journal:  J Pharmacol Exp Ther       Date:  2013-01-18       Impact factor: 4.030

2.  Deranged NMDAergic cortico-subthalamic transmission underlies parkinsonian motor deficits.

Authors:  Ming-Kai Pan; Chun-Hwei Tai; Wen-Chuan Liu; Ju-Chun Pei; Wen-Sung Lai; Chung-Chin Kuo
Journal:  J Clin Invest       Date:  2014-09-09       Impact factor: 14.808

3.  Antiarrhythmics cure brain arrhythmia: The imperativeness of subthalamic ERG K+ channels in parkinsonian discharges.

Authors:  Chen-Syuan Huang; Guan-Hsun Wang; Chun-Hwei Tai; Chun-Chang Hu; Ya-Chin Yang
Journal:  Sci Adv       Date:  2017-05-10       Impact factor: 14.136

4.  Maladaptive Downregulation of Autonomous Subthalamic Nucleus Activity following the Loss of Midbrain Dopamine Neurons.

Authors:  Eileen L McIver; Jeremy F Atherton; Hong-Yuan Chu; Kathleen E Cosgrove; Jyothisri Kondapalli; David Wokosin; D James Surmeier; Mark D Bevan
Journal:  Cell Rep       Date:  2019-07-23       Impact factor: 9.423

Review 5.  Cellular and Synaptic Dysfunctions in Parkinson's Disease: Stepping out of the Striatum.

Authors:  Nicolas Mallet; Lorena Delgado; Marine Chazalon; Cristina Miguelez; Jérôme Baufreton
Journal:  Cells       Date:  2019-08-29       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.